Lanabecestat（AZD3293, LY3314814）
99%
- Product Code: 202366
CAS:
1383982-64-6
| Molecular Weight: | 412.53 g./mol | Molecular Formula: | C₂₆H₂₈N₄O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in clinical research for the treatment of early Alzheimer’s disease. Designed to inhibit BACE1 (beta-secretase), an enzyme involved in the production of amyloid-beta peptides. By reducing amyloid-beta accumulation in the brain, it aimed to slow disease progression. Despite promising mechanism, clinical development was discontinued due to lack of efficacy in late-stage trials.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1mg | 10-20 days | ฿9,440.00 |
+
-
|
Lanabecestat（AZD3293, LY3314814）
Used in clinical research for the treatment of early Alzheimer’s disease. Designed to inhibit BACE1 (beta-secretase), an enzyme involved in the production of amyloid-beta peptides. By reducing amyloid-beta accumulation in the brain, it aimed to slow disease progression. Despite promising mechanism, clinical development was discontinued due to lack of efficacy in late-stage trials.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :